178 related articles for article (PubMed ID: 18843342)
1. A network solution.
Henney A; Superti-Furga G
Nature; 2008 Oct; 455(7214):730-1. PubMed ID: 18843342
[No Abstract] [Full Text] [Related]
2. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
3. Embracing complexity in drug discovery.
Gund P; Maliski E; Brown F
Curr Opin Drug Discov Devel; 2007 May; 10(3):252-3. PubMed ID: 17554850
[No Abstract] [Full Text] [Related]
4. Omics: tools for studying and understanding systems toxicology.
Mahadevan B
Mutat Res; 2010 Dec; 705(3):163-4. PubMed ID: 20554060
[No Abstract] [Full Text] [Related]
5. Top-down standards will not serve systems biology.
Quackenbush J; Stoeckert C; Ball C; Brazma A; Gentleman R; Huber W; Irizarry R; Salit M; Sherlock G; Spellman P; Winegarden N
Nature; 2006 Mar; 440(7080):24. PubMed ID: 16511469
[No Abstract] [Full Text] [Related]
6. New screening tools for lead compound identification.
Sawyer TK
Nat Chem Biol; 2005 Aug; 1(3):125. PubMed ID: 16408012
[No Abstract] [Full Text] [Related]
7. Systems biology: Metabonomics.
Nicholson JK; Lindon JC
Nature; 2008 Oct; 455(7216):1054-6. PubMed ID: 18948945
[No Abstract] [Full Text] [Related]
8. Preclinical drug discovery research and training at Vanderbilt.
Lindsley CW; Weaver D; Jones C; Marnett L; Conn PJ
ACS Chem Biol; 2007 Jan; 2(1):17-20. PubMed ID: 17243778
[No Abstract] [Full Text] [Related]
9. Pathways, networks, and systems medicine--the meeting place of the Aegean and the mind.
Subramaniam S; Nadeau JH
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):253-4. PubMed ID: 21462354
[No Abstract] [Full Text] [Related]
10. From glycobiology to systems glycobiology: international network with Japanese scientists through consortia.
Taniguchi N
IUBMB Life; 2006; 58(5-6):269-72. PubMed ID: 16754315
[No Abstract] [Full Text] [Related]
11. Several novel approaches to developing therapeutics that target both bacterial and human proteins.
Mapp A; Romesberg FE
Curr Opin Chem Biol; 2008 Aug; 12(4):387-8. PubMed ID: 18707019
[No Abstract] [Full Text] [Related]
12. [Application of protein chip in drug research and development].
Zhou Y; Geng MY; Du GH
Yao Xue Xue Bao; 2004 Apr; 39(4):312-6. PubMed ID: 15303667
[No Abstract] [Full Text] [Related]
13. High drug attrition rates--where are we going wrong?
Hutchinson L; Kirk R
Nat Rev Clin Oncol; 2011 Mar; 8(4):189-90. PubMed ID: 21448176
[No Abstract] [Full Text] [Related]
14. Benefits and limits of model systems in developmental biology and toxicology (in vitro techniques).
Neubert D
Prog Clin Biol Res; 1985; 163A():91-6. PubMed ID: 3969395
[No Abstract] [Full Text] [Related]
15. International Workshop on the Use of Pharmacological Methods in Safety-Evaluation of New Drugs, 1977. Proceedings.
Pharmacol Ther B; 1979; 5(1-3):1-605. PubMed ID: 493303
[No Abstract] [Full Text] [Related]
16. NIMH Preclinical/Clinical Therapeutics Research meeting--preclinical drug discovery session.
Douglas SD
J Neuroimmune Pharmacol; 2007 Mar; 2(1):5-7. PubMed ID: 18040819
[No Abstract] [Full Text] [Related]
17. Systems biology could help us harness useful microbes.
Young D
Nature; 2006 Aug; 442(7103):627. PubMed ID: 16900178
[No Abstract] [Full Text] [Related]
18. Uncertainty factors in noncancer risk assessment.
Dourson M
Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):107. PubMed ID: 8933623
[No Abstract] [Full Text] [Related]
19. Metabonomics in the preclinical and environmental toxicity field.
Colet JM
Drug Discov Today Technol; 2015 Jun; 13():3-10. PubMed ID: 26190677
[TBL] [Abstract][Full Text] [Related]
20. Symposium on Present Status and Goals of Collaborative Studies in Toxicology. 92nd Annual Meeting of the AOAC, October 1978.
J Assoc Off Anal Chem; 1979 Jul; 62(4):832-916. PubMed ID: 40949
[No Abstract] [Full Text] [Related]
[Next] [New Search]